Virtual Event | October 10, 2024

Selecting & Managing CDMOs For Novel Therapies

Source: Outsourced Pharma

Outsourced Pharma Live welcomes Verve Therapeutics' Praveen Prasanna, Ph,D., GenSight Biologics' Scott Jeffers, and University of Minnesota's Vaibhav Patel to explore the critical considerations and best practices for selecting and managing CDMOs in the development of novel therapies, including advanced therapy medicinal products like cell and gene therapies.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)